1 / 9

Hyoscine-N-Butyl Bromide Market Competition Tracking- Key Market Insights 2018-2027

The Hyoscine-N-Butyl Bromide market was valued at over US$ 50 million in 2018 and is projected to register Y-O-Y growth of 4.3% in 2019.<br>

nimittmr
Download Presentation

Hyoscine-N-Butyl Bromide Market Competition Tracking- Key Market Insights 2018-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hyoscine-N-Butyl Bromide Market Forecast, Trend Analysis & Competition Tracking- Global Market Insights 2018-2027 Chemical & Materials 17O Pages Published : Mar 2019

  2. Market Snapshot

  3. Description Hyoscine-N-Butyl Bromide used to treat abdominal pain and spasms is available in both oral and injectable form. However, with increasing sales of Hyoscine-N-Butyl Bromide under the brandnameBuscopan which is an oral medication, the application of Hyoscine-N-Butyl Bromide in oral form is gaining traction. Moreover, with a range of benefits on oral administration of Hyoscine-N-Butyl Bromide, it is being used on a large scale. Upon oral administration, it binds and blocks muscarinic receptors, thereby, providing anti-spasmodic effect in the uterine, gastrointestinal, and urinary tracts.  The report on the Hyoscine-N-Butyl Bromide market serves as an authentic dataset for readers and players to plan business strategies in order to stay competitive in the Hyoscine-N-Butyl Bromide market.   

  4. Hyoscine-N-Butyl Bromide Market- Key Insights • Worldwide sales of Hyoscine-N-Butyl Bromide recorded a steady growth by registering 4.0% CAGR between 2013 and 2017. However, the market is likely to witness significant growth in the coming years owing to its wide application in treating various conditions and acting as muscle relaxant. • The Hyoscine-N-Butyl Bromide market was valued at over US$ 50 million in 2018 and is projected to register Y-O-Y growth of 4.3% in 2019. • Europe is expected to be the largest region in the Hyoscine-N-Butyl Bromide market during the forecast period and account for an estimated 34.6% share by 2019 end.

  5. Assessment of Competitive Landscape • BoehringerIngelheim has filed for the regulatory approval of Nintedanib for patients with systemic sclerosis associated interstitial lung disease with the EMA and FDA. Recently, Boehringer also entered into a research collaboration with GNA Biosolutions to develop emergency veterinary diagnostics, including rapid diagnostic test for African swine fever that can be used on the portable molecular diagnostic platform by GNA. • The FDA has approved DicyclomineHCl Injection, the generic version of Bentyl Injection by Aptalis Pharma. DicyclomineHCl is an anti-spasmodic and anti-cholinergic agent that helps to relieve smooth muscle spasms in the gastrointestinal tract. The injection is supplied as 20mg/2ml.

  6. Table of Contents 1. Global Hyoscine-N-Butyl Bromide Market - Executive Summary 2. Global Hyoscine-N-Butyl Bromide Market Overview     2.1. Introduction            2.1.1. Global Hyoscine-N-Butyl Bromide Market Taxonomy            2.1.2. Global Hyoscine-N-Butyl Bromide Market Definition     2.2. Global Hyoscine-N-Butyl Bromide Market Size (US$ Mn) and Forecast, 2013-2027            2.2.1. Global Hyoscine-N-Butyl Bromide Market Y-o-Y Growth     2.3. Global Hyoscine-N-Butyl Bromide Market Dynamics     2.4. Supply Chain     2.5. Cost Structure     2.6. Pricing Analysis      2.7. Raw Material Sourcing Strategy and Analysis     2.8. Service Provider List     2.9. Key Participants Market Presence (Intensity Map) By Region

  7. 3. Global Hyoscine-N-Butyl Bromide Market Analysis and Forecast 2013-2027      3.1. Global Hyoscine-N-Butyl Bromide Market Size and Forecast By Application, 2013-2027            3.1.1. Oral Market Size and Forecast, 2013-2027                     3.1.1.1. Revenue (US$ Mn) Comparison, By Region                     3.1.1.2. Market Share Comparison, By Region                     3.1.1.3. Y-o-Y growth Comparison, By Region            3.1.2. Injectables Market Size and Forecast, 2013-2027                     3.1.2.1. Revenue (US$ Mn) Comparison, By Region                     3.1.2.2. Market Share Comparison, By Region                     3.1.2.3. Y-o-Y growth Comparison, By Region 4. North America Hyoscine-N-Butyl Bromide Market Size and Forecast, 2013-2027     4.1. Revenue (US$ Mn) Comparison, By Country      4.2. Revenue (US$ Mn) Comparison, By Application 

  8. Scope The scope of Fact.MR’s report is to analyze the Hyoscine-N-Butyl Bromide market for the forecast period 2018-2027 and provide readers an unbiased and accurate analysis. Hyoscine-N-Butyl Bromide manufacturers, stakeholders, and suppliers involved in the Hyoscine-N-Butyl Bromide market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to incumbent players and new entrants looking to enter the Hyoscine-N-Butyl Bromide market. Summary The report commences with a brief information of the Hyoscine-N-Butyl Bromide market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the Hyoscine-N-Butyl Bromide market. Request Free Sample Report

  9. Get In Touch • Want Tailor-made Report? Enquire at sales@factmr.com Now! Suite 9884 27 Upper Pembroke Street, Dublin 2, Ireland Toll Free : +353-1-6111-593Email : sales@factmr.comWebsite: https://www.factmr.com/

More Related